Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

EscharEx is currently being investigated in a global Phase III study for the treatment of venous leg ulcers (VLUs ... MediWound's first drug, NexoBrid ®, is an FDA- and EMA-approved orphan biologic ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically.